Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1648 1653 1671
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18151174 | NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18552167 | Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibody | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 18022056 | ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS | Non-Final OA | California Institute of Technology |
| 17296829 | T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses | Non-Final OA | The General Hospital Corporation |
| 18548708 | CAPILLARY ELECTROPHORESIS METHODS FOR QUANTIFYING VIRAL SPECIES | Non-Final OA | DH Technologies Development Pte. Ltd. |
| 17802443 | METHOD FOR REMOVING HOST CELL DNA FROM VIRUS PREPARATION | Non-Final OA | Takeda Vaccines, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy